文献速递头颈外科

头颈部腺样囊性癌的生存结局:17 497例的系统评价与Meta分析

Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta-Analysis.
PubMed 文献 · Head Neck · 2025-03-18

该系统评价与Meta分析检索了MEDLINE、PubMed、Scopus和EMBASE,纳入57项研究共17 497例头颈部腺样囊性癌患者,分析生存结局及不良预后相关因素。远处转移是最常见的不良结局,平均发生于34.8个月;5年、10年、15年和20年生存率分别为73.8%、48.5%、42.3%和26.5%。不良生存预测因素包括晚期T分期、淋巴结阳性、实性肿瘤、远处转移和手术切缘阳性。

要点

  • 远处转移是头颈部腺样囊性癌最常见的不良结局,平均发生于34.8个月。
  • 5年、10年、15年和20年生存率分别为73.8%、48.5%、42.3%和26.5%。
  • 不良生存预测因素包括晚期T分期、淋巴结阳性、实性肿瘤、远处转移和手术切缘阳性。

核心结论

  • 远处转移是腺样囊性癌最常见的不良结局,预后因素与晚期肿瘤和残留肿瘤相关。

研究设计与样本

  • 系统评价与Meta分析,检索MEDLINE、PubMed、Scopus和EMBASE,检索日期为2024年3月25日。
  • 纳入分析腺样囊性癌生存的研究,排除缺乏生存数据或仅关注单一腺样囊性癌部位的研究。
  • 共纳入57项研究,17 497例患者;使用Joanna Briggs Institute关键评价工具评估偏倚风险,采用R软件进行Meta分析。

主要发现

  • 腺样囊性癌主要影响女性(平均年龄52.69岁),主要发生于小唾液腺。
  • 远处转移是最常见的不良结局,平均发生于34.8个月;区域淋巴结转移和局部复发分别平均发生于27.5个月和31.3个月。
  • 5年、10年、15年和20年生存率分别为73.8%、48.5%、42.3%和26.5%。
  • 不良生存预测因素包括晚期T分期、淋巴结阳性、实性肿瘤、远处转移和手术切缘阳性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adenoid cystic carcinoma (ACC) is a slow-growing tumor with variable outcomes, making follow-up protocols challenging. This review analyzed outcomes in ACC, focusing on patterns and factors related to adverse prognoses. METHODS: A search was conducted on March 25, 2024, in MEDLINE, PubMed, Scopus, and EMBASE. Studies analyzing ACC survival were included, while those lacking these data or focusing on a single ACC site were excluded. The Joanna Briggs Institute's Critical Appraisal tool was used to assess the risk of bias, and the metanalysis was performed using R software. RESULTS: Among 57 studies (17 497 patients), ACC predominantly affected women (mean age: 52.69 years) and occurred mainly in minor salivary glands. Distant metastasis was the most frequent adverse outcome, occurring at 34.8 months on average. Locoregional metastasis and local recurrence occurred at 27.5 and 31.3 months, respectively. Five-, 10-, 15-, and 20-year survival rates were 73.8%, 48.5%, 42.3%, and 26.5%, respectively. Poor survival predictors included advanced T stage, positive lymph nodes, solid tumors, distant metastasis, and positive surgical margins. CONCLUSIONS: Distant metastasis is the most frequent adverse outcome in ACC, and prognostic factors are related to advanced and residual tumors.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Lavareze L, Kimura TC, Cacita N, et al. Survival Outcomes in Adenoid Cystic Carcinoma of the Head and Neck: A Systematic Review of 17 497 Cases and Meta-Analysis. Head Neck. 2025. PMID: 40098462. doi:10.1002/hed.28132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。